This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Universite Paris Cité. Active years: 2022-2023.
Company Filing History:
2 out of 5,383 
2 out of 1,853 
1 out of 72 
Years Active: 2022-2023
Title: Anaïs Domingot: Innovator in Cancer Diagnosis and Treatment
Introduction
Anaïs Domingot is a prominent inventor based in Paris, France. He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of HER2-dependent cancers. With a focus on micro ribonucleic acids (miRNAs), his work has the potential to improve patient outcomes through innovative diagnostic methods and therapeutic agents.
Latest Patents
Anaïs Domingot holds 2 patents related to his groundbreaking work. His first patent involves a method for diagnosing and/or prognosticating HER2-dependent cancer using specific miRNAs as biomarkers. This method includes measuring the levels of selected miRNAs in a subject's sample, comparing these levels to reference values, and determining the diagnosis based on any deviations found. His second patent focuses on the treatment of HER2-dependent cancer using agents that modulate the activity of specific miRNAs, offering a novel approach to cancer therapy.
Career Highlights
Throughout his career, Anaïs Domingot has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His research has been pivotal in advancing the understanding of miRNAs in cancer biology and their potential applications in clinical settings.
Collaborations
Anaïs has collaborated with notable colleagues, including Sandrine Bourdoulous and Camille Faure. These partnerships have fostered a collaborative environment that enhances the research and development of innovative cancer treatments.
Conclusion
Anaïs Domingot's contributions to cancer research through his patents and collaborations highlight his role as a leading inventor in the field. His work not only advances scientific knowledge but also holds promise for improving cancer diagnosis and treatment.